DCDivya A. Chari

Divya A. Chari

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Divya A. Chari has a total of 43 co-authors. Here are the top co-authors by number of shared publications:

  • Amy F. Juliano

    Department of Radiology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA

    3 shared publications
  • Richard F. Lewis

    Jenks Vestibular Physiology Laboratory, Massachusetts Eye and Ear, Boston, MA, USA

    3 shared publications
  • Steven D. Rauch

    Department of Otolaryngology-Head and Neck Surgery, Harvard Medical School, Boston, MA, USA

    3 shared publications
  • Andrew W. Liu

    University of Massachusetts Chan School of Medicine Worcester Massachusetts USA

    2 shared publications
  • Arpan Bose

    University of Massachusetts Chan Medical School, Worcester, MA, USA

    2 shared publications
  • Kimberly Ramirez

    University of Massachusetts Chan Medical School, Worcester, MA, USA

    2 shared publications

Latest Publications

  • Open Access

    Short‐ Versus Long‐Term Hearing Preservation and Speech Recognition Outcomes in Precurved and Straight Electrode Arrays

    by Lily V. Den Hartog, Andrew W. Liu, Divya A. Chari

    Objective: Compare audiologic outcomes between precurved and straight electrode arrays in cochlear implant (CI) recipients while controlling for age and preoperative hearing in a large cohort. Study Design: Retrospective chart review. Setting: Tertiary referral center. Methods: Adult CI recipients who underwent surgery from 2018 to 2025 with Cochlear Americas slim modiolar CI532/632 (precurved) or slim straight CI522/622 (straight) electrode arrays were included. Preimplantation and postimplantation low‐frequency pure tone average (LFPTA) in the short‐ (1‐ and 6‐months) and long‐term (≥12 months) and speech recognition testing (CNC, AzBio in quiet) at 1‐, 3‐, 6‐, and 12‐months postactivation were recorded. Hearing preservation (LFPTA shift) and speech recognition scores were evaluated using multivariate linear regression analysis. Results: One hundred seventy‐two patients (190 ears) were included. 124 (65.3%) and 66 (34.7%) ears were implanted with a precurved or straight electrode, respectively. 47 (24.7%) ears had residual hearing (LFPTA ≤ 80) preoperatively. Precurved electrode recipients had significantly better hearing preservation compared to straight electrode recipients in the short‐term ( F = 4.016, P = .039), though this advantage diminished in long‐term follow‐up after controlling for age, sex, and preoperative LFPTA. CNC and AzBio scores were not significantly different between electrode arrays at any timepoint postimplantation. Conclusion: Precurved electrodes were associated with small but statistically significant greater hearing preservation in the short‐term compared to straight electrodes, but this difference did not persist in the long‐term. Speech recognition outcomes were similar for precurved and straight electrodes at all timepoints. These findings should be considered during preoperative decision‐making for potential CI recipients.

  • Open Access

    PHEX Gene Dosage Drives Meniere’s Disease and Related Audiovestibular Phenotypes in X-Linked Hypophosphatemia

    by Paula Robles-Bolivar, David Bäechinger, Arpan Bose, Kimberly Ramirez, Alison Brown, Amy F. Juliano, Jose Antonio Lopez-Escamez, Sharon G. Kujawa, Eva S. Liu, Sami S. Amr, et al.

    Importance: A subset of Meniere’s disease (MD) patients—defined by endolymphatic sac underdevelopment (ES hypoplasia), frequent bilateral disease, and strong male predominance—termed “MD-hp”, has emerged as a promising model for genetic investigation. We observed a striking enrichment of X-linked hypophosphatemia (XLH) caused by PHEX mutations among MD-hp patients, suggesting a shared genetic driver and immediate opportunities for biomarker discovery and targeted therapy development. Objective: To test whether XLH and MD-hp share a causal, PHEX gene-driven relationship. Design: Prospective, cross-sectional observational study. Setting: Two tertiary academic centers. Participants: Thirty-three adult XLH patients. Main Outcome Measures: Pure-tone audiometry and speech-intelligibility testing; vestibular function via caloric and video head-impulse testing; symptom history fulfilling definite MD criteria; high-resolution CT assessment of ES hypoplasia (ATVA ≥ 140°) to define MD-hp; delayed 3D-FLAIR MRI detection of endolymphatic hydrops; and PHEX /pathway gene sequencing. Results: Given population prevalences (XLH ≈ 0.005%; MD ≈ 0.2%; MD-hp ∼30% of MD), random co-occurrence would be ∼1 in 33 million. In our cohort, 6 of 33 met bilateral MD-hp criteria (XLH+MD-hp ≈ 18.2%; 1 in 5.5)—a > 6 million-fold enrichment—all hemizygous males (including two with fluctuating progressive sensorineural hearing loss (SNHL) but no vertigo). Two additional hemizygous males < 40 years of age displayed bilateral ES hypoplasia without clinical MD, and two males with mosaic or hypomorphic PHEX variants showed normal ES anatomy and no audiovestibular symptoms. No female carriers met MD-hp criteria; instead, five exhibited mild-to-moderate low-to-mid frequency sensorineural hearing loss without vertigo, and two had isolated conductive hearing loss. Conclusions and Relevance: These findings support an inner ear–specific PHEX gene-dosage threshold model for MD-hp penetrance: complete loss-of-function in hemizygous males leads to bilateral ES hypoplasia and MD, whereas mosaic or partialLJloss variants in males—and heterozygosity in females—permit residual PHEX activity, resulting in milder or absent audiovestibular phenotypes. This genotype– endotype–phenotype linkage (complete PHEX loss → ES hypoplasia → MD) enables early risk stratification, personalized surveillance, and paves the way for targeted therapies in XLH patients.


  • Do Children With Cochlear Nerve Deficiency Benefit From Cochlear Implantation?

    by Rishi K. Vas, Divya A. Chari, Anil K. Lalwani

  • Top Cited Papers
    Open Access

    A modern conceptual framework for study and treatment of Meniere’s disease

    by Divya A. Chari, Arpan Bose, Kimberly Ramirez, Paula Robles-Bolivar, Kuei-You Lin, Amy F. Juliano, Steven D. Rauch, Andreas H. Eckhard

    Prosper Meniere made his immortal contribution to the field of otology in 1861. At that time, all manner of “fits” were lumped together under the diagnosis of “apoplectiform cerebral congestion”—too much blood in the brain. His genius was to identify a specific subset of this heterogeneous pool whose cardinal symptoms, tinnitus, fluctuating progressive deafness, and episodic vertigo, were due to dysfunction of the inner ear. Seventy-seven years later, in 1938, Hallpike and Cairns in England and Yamakawa in Japan identified cochleosaccular endolymphatic hydrops (EH) as the histopathologic correlate of Meniere’s disease (MD). Over the 85 years since then, many theories to explain the symptoms of MD have come and gone. A consensus has slowly emerged that patients with this condition have a failure of inner ear homeostasis. The cause(s) of this homeostatic failure and the mechanism(s) by which this failure leads to fluctuating progressive sensorineural hearing loss and episodic vertigo has remained elusive. In the last few years, new techniques and findings in temporal bone histopathology and in vivo temporal bone imaging have yielded breakthroughs in this field. We are now recapitulating Meniere’s approach by taking the heterogeneous population of patients with MD and segregating them into specific subtypes based upon clinical phenotype. Salient clinical features include vestibular aqueduct and endolymphatic sac morphology, age at symptom onset, sex, and incidence of bilateral involvement. Furthermore, new imaging modalities enable unequivocal diagnosis of EH, transitioning MD from a “clinical” diagnosis to one based upon specific objective criteria. These breakthroughs have opened the door to genetic analyses, consideration of comorbid clinical disorders, especially migraine, and potential new treatments, and demand that we revisit all the various treatments that have been considered previously. They also demand new and more stringent criteria for any publication about this condition. In this paper we will review these new findings, discuss their immediate implications for clinical practice, and consider some of the most pressing research questions for near- and long-term address.


  • Open Access

    Comparative utility of vestibular function tests in patients with peripheral and central vestibular dysfunction

    by Cameron B. Fattahi, Christopher Zaro, Janice J. Chung, Richard F. Lewis, Divya A. Chari

    Bithermal caloric irrigation, video head impulse test (vHIT), and rotational testing are commonly used to assess peripheral vestibular function, but the relative clinical utility of each test in differentiating patients with peripheral vestibulopathy is debated. To determine whether (1) the combination of two or more vestibular tests enhances diagnostic utility over a single test; (2) abnormal test results on vestibular tests correlate with one another. Retrospective analysis of data collected from multidisciplinary vestibular clinics at two academic medical centers from 2016 to 2022. 150 patients (54.10 ± 15.09 years, 88 females) were included. No individual test was significantly better at predicting the presence of peripheral vestibular damage (p > 0.05). vHIT test results improved significantly when combined with either the caloric test (p = 0.007) or rotary chair test (p = 0.039). Caloric and rotational testing had high sensitivity (74.65% and 76.06%, respectively) and specificity (83.54% and 78.48%, respectively). vHIT demonstrated excellent specificity (89.87%) but poor sensitivity (47.89%). Caloric, vHIT, and rotary chair tests results did not correlate with one another (p > 0.05). Vestibular function tests have comparable diagnostic utility, yet each offers unique advantages. Caloric and rotational testing may be best suited for screening peripheral damage and vHIT may function ideally as a confirmatory test.


  • Visuospatial Cognitive Dysfunction in Patients with Vestibular Loss

    by Maimuna Ahmad, Lukasz Bola, Anissa Boutabla, Susan King, Richard F. Lewis, Divya A. Chari

    Objective: To characterize visuospatial and nonvisuospatial cognitive domains affected by vestibular loss and determine whether patient-reported outcomes measures (PROMs) correlate with performance on neuropsychological tests. Study Design: Cross-sectional study. Setting: University-based tertiary medical center. Patients: Sixty-nine age-matched subjects: 25 patients with bilateral vestibular loss (BVL), 14 patients with unilateral vestibular loss (UVL), and 30 normal controls (NC). Interventions: Neuropsychological tests used to assess visuospatial and auditory short-term and working memory, number magnitude representation, executive function, and attention. Validated PROMs used to evaluate quality of life and subjective cognitive impairment. Main Outcome Measures: Performance on neuropsychological tests and scores on PROM surveys. Results: BVL and UVL patients performed significantly worse than NC subjects on tasks requiring visuospatial representation compared with NC subjects (p < 0.01). BVL patients demonstrated decreased performance on spatial representation tasks compared with UVL and NC subjects (p < 0.05 and p < 0.05, respectively). All subject groups performed similarly on tasks assessing nonvisuospatial cognitive domains, such as auditory short-term and working memory, executive function, and attention. PROMs did not seem to correlate with performance on neuropsychological tasks. Conclusion: Patients with vestibular loss exhibit impairments in tasks requiring visuospatial representation but perform similarly to NC subjects in tasks of auditory working memory, executive function, or attention. Currently available questionnaires may be insufficient to screen patients for cognitive deficits.


  • Evidence for cognitive impairment in patients with vestibular disorders

    by Divya A. Chari, Amsal Madhani, Jeffrey D. Sharon, Richard F. Lewis

    Objective Extensive animal research has shown that vestibular damage can be associated with cognitive deficits. More recently, new evidence has emerged linking vestibular disorders to cognitive impairment in humans. Herein, we review contemporary research on the pathophysiology of cognitive-vestibular interactions and discuss its emerging clinical relevance. Data sources PubMed, Embase, and Cochrane databases. Review methods A systematic literature search was performed with combinations of search terms: “cognition,” “cognitive impairment,” “chronic fatigue,” “brain fog,” “spatial navigation,” “attention,” “memory,” “executive function,” “processing speed,” and “vestibular hypofunction.” Relevant articles were considered for inclusion, including basic and clinical studies, case series, and major reviews. Conclusions Patients with vestibular disorders can demonstrate long-term deficits in both spatial and nonspatial cognitive domains. The underlying mechanism(s) linking the vestibular system to cognitive function is not well characterized, but several neuro-biologic correlates have been identified. Additional screening tools are required to identify individuals at risk for cognitive impairment, and further research is needed to determine whether treatment of vestibular dysfunction has the capacity to improve cognitive function. Implications for practice Physicians should be aware of emerging data supporting the presence of cognitive deficits in patients with vestibular disorders. Prevention and treatment of long-term cognitive deficits may be possible through screening and rehabilitation.